Ranitidine in shortage till mid-2020

The TGA has issued new advice for consumers about ranitidine, following the recent recall Earlier this month it recalled a number of brands of the heartburn medication, including Aspen’s Zantac, as there had been contamination with an impurity called N‑nitrosodimethylamine (NDMA). It is now advising that it has tested 135 different batches of medicines containing ranitidine,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘We have no intention in changing the rules.’
Next The week in review